Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-12-265222
Filing Date
2012-06-08
Accepted
2012-06-08 16:36:56
Documents
11
Period of Report
2012-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d364463d6k.htm 6-K 11222
2 PRESS RELEASE d364463dex991.htm EX-99.1 7248
3 PRESS RELEASE d364463dex992.htm EX-99.2 5817
4 INVESTOR UPDATE d364463dex993.htm EX-99.3 26858
5 GRAPHIC g364463g11k91.jpg GRAPHIC 303435
6 GRAPHIC g364463g26w55.jpg GRAPHIC 291028
7 GRAPHIC g364463g37q61.jpg GRAPHIC 352352
8 GRAPHIC g364463g48f73.jpg GRAPHIC 318014
9 GRAPHIC g364463g62m31.jpg GRAPHIC 309546
10 GRAPHIC g364463g67e02.jpg GRAPHIC 308655
11 GRAPHIC g364463g78v31.jpg GRAPHIC 24835
  Complete submission text file 0001193125-12-265222.txt   2681758
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 12898275
SIC: 2834 Pharmaceutical Preparations